01 3Leqvio
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 12
2020 Revenue in Millions : 0
Growth (%) : New Launch in 2021
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 112
2021 Revenue in Millions : 12
Growth (%) : 833
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 355
2022 Revenue in Millions : 112
Growth (%) : 217
LOOKING FOR A SUPPLIER?
